Vaccine maker recounts “breakfast table” pivot to covid work Posted on 17.12.202015.03.2023 by Laura Pivac-Bieser
European innovation reaches EU population: MIG Fonds` portfolio company BioNTech achieves positive CHMP opinion for the first COVID-19 and mRNA vaccine Posted on 21.12.202013.04.2022 by bitlane_admin
